The Dravet Syndrome Foundation (DSF) is funding a collaborative research project to provide a framework for artificial intelligence (AI)-based…
Articles by Marisa Wexler, MS
A novel gene therapy that works to increase the levels of an enzyme called p38-gamma extended survival and reduced seizure…
The Dravet Syndrome Foundation (DSF) has announced the award of $690,000 in total research funding for five projects that…
Not only do young people with Dravet syndrome show cognitive, developmental and behavioral differences compared with their normally developing…
The U.S. Food and Drug Administration has expanded its approval of the anticonvulsant Diacomit (stiripentol) — when used as…
There are close statistical associations between seizure frequency and the severity of other disease symptoms, such as language problems, in people…
Japan’s Ministry of Health, Labour and Welfare has approved oral Fintepla (fenfluramine) as an add-on treatment for seizures associated…
Treatment with soticlestat significantly reduced seizure frequency for children with Dravet syndrome or Lennox-Gastaut syndrome (LGS), another childhood…
Adults with Dravet syndrome commonly experience walking difficulties that tend to worsen with age, a small study reports. “In…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…